abstract |
The invention relates to 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as selective blockers of TASK-1 and TASK-3 channels, for the treatment and/or prevention of breathing disorders including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring. |